Feb 20, 2024
Nabiximols, a cannabis-based oral spray sold as Sativex, was reported to considerably ease spasticity — unusual muscle tightness or stiffness — in about two-thirds of the multiple sclerosis (MS) patients using it for three months in a real-world study in Germany. For...
Feb 18, 2024
Join Denise Ellis this coming Wednesday and Thursday, February 21st and 22nd online as she walks us through the process of getting a March is MS Awareness Month Proclamation from your municipality. Wednesday February 21 – 6:30 pm to 7:30 pm Thursday February 22...
Feb 8, 2024
How does the brain rid itself of waste, and how does this process influence our health? In a landmark study led by researchers at Washington University in St. Louis and the National Institute of Neurological Disorders and Stroke, scientists have uncovered a direct...
Jan 31, 2024
Kyverna Therapeutics has developed a method that enables KYV-101, an experimental CAR T-cell therapy for multiple sclerosis (MS) and other conditions, to be produced in a much shorter timeframe than conventional manufacturing processes, a study shows. The approach...
Jan 31, 2024
The U.S. Patent and Trademark Office (USPTO) has notified Vanda Pharmaceuticals that it will grant a new patent covering the use of Ponvory (ponesimod), an approved oral treatment for relapsing forms of multiple sclerosis (MS), that will span nearly two decades, the...
Jan 31, 2024
Over the past few years, my verbal communication skills have slowly diminished. My diagnosis has had negative impact on my speech. The muscles in my mouth and throat have become extremely weak, increasing my inability to speak clearly. Most times, early in the day, I...
